ArticleAnnals of medicine2025

Amylin inhibits gastric cancer progression by targeting CCN1 and affecting the PI3K/AKT signalling pathway.

Li Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.